期刊文献+

膀胱移行上皮癌组织端粒酶活性的检测及意义 被引量:8

Study of telomerase activity in transitional cell carcinoma of the bladder
下载PDF
导出
摘要 目的:为了探讨端粒酶与膀胱移行上皮癌(TCC)及其生物学行为的关系。方法:应用端粒酶重复序列扩增法(TRAP法)检测42例TCC组织及12例正常膀胱粘膜组织的端粒酶活性,并分析端粒酶活性与TCC病理分化程度、浸润深度、肿瘤发生的多中心性及肿瘤复发等生物学行为的关系。结果:TCC组织中端粒酶活性阳性率为85.7%(36/42),而正常膀胱粘膜组织端粒酶活性阳性率为0.0%(0/12),两者比较有显著的统计学差异(P<0.01);不同病理分化程度、浸润深度及单发或多发TCC组织中的端粒酶活性阳性率无显著的统计学差别(P均>0.05);术后肿瘤复发者的端粒酶活性阳性率为100%(8/8),而未复发者的端粒酶活性阳性率为82.3%(28/34),两者比较有显著的统计学差异(P<0.05)。结论:本实验结果表明TCC组织中端粒酶活性阳性率明显高于正常膀胱粘膜组织,术后肿瘤复发者的端粒酶活性阳性率明显高于未复发者。而TCC病理分化程度、浸润深度及肿瘤发生的多中心性等生物学行为与端粒酶活性未见有相关性。因此,端粒酶活性有可能作为TCC早期诊断、鉴别诊断及预测肿瘤复发的标志物。 Objective: To investigate telomerase activity in transitional cell carcinoma of the bladder (TCC) and its relationship to the biological malignant potentials of TCC. Methods: Using polymerase chain reaction-based telomeric repeat amplification protocol assay, we examined telomerase activity in 42 TCC tissues and 12 normal bladder tissues. Results: Telomerase activity was detected in 36 of 42 (85. 7% ) TCC tissues, and none of 12 normal bladder tissues (0. 0% ), the positive rate of telomerase activity in TCC was significantly higher than that in normal bladder tissues (P < 0. 01 ). There was a correlation between the positive rate of telomerase activity and the status of tumor recurrence (P < 0.05), but unexpectedly, no significant correlation was observed between the positive rate of telomerase activity and the clinicopathologic features of TCC, including pathologic grade, clinical stage and tumor mutiplicity (P > 0. 05). Conclusions: This study suggests that telomerase activition may be a critical step in the pathogenesis of TCC and that telomerase activity might be a useful tool for detecting TCC and predicting recurrence of TCC; but there was no significant correlation between telomerase activity and the clinicopathologic features of TCC, although further studies are required to clarify this point.
出处 《癌症》 SCIE CAS CSCD 北大核心 2000年第1期75-77,共3页 Chinese Journal of Cancer
基金 广东省医药卫生科学基金!(编号:1998155)
关键词 膀胱肿瘤 端粒酶 诊断 膀胱移行上皮癌 Bladder neoplasms Telomerase Diagnosis
  • 相关文献

参考文献5

二级参考文献104

共引文献9945

同被引文献52

  • 1邱慧兵,周云峰,周福祥,谢丛华,骆志国,於海军,刘诗权.RNA干扰抑制Hep-2细胞人端粒酶逆转录酶基因表达对放射敏感性的影响[J].中华肿瘤杂志,2007,29(1):9-13. 被引量:9
  • 2胡金钟,汪定海,傅祝能,单小云,徐瑞龙.端粒酶PCR SCE检测对诊断膀胱癌的价值及应用[J].浙江临床医学,2007,9(2):151-152. 被引量:2
  • 3闫骏,袁亚光.晨尿脱落细胞端粒酶活性检测在膀胱癌中的诊断价值[J].内蒙古医学杂志,2007,39(5):525-527. 被引量:3
  • 4Toshikuni N, Nouso K, Higashi T, et al. Expression of telomerase- associated protein and telomerase reverse transcriptase in hepatocellular carcinoma [ J ]. Br J Cancer, 2000,82(4) :833 -837.
  • 5Iord RV, Salonga D, Daneberg KD, et al. Telomerase reverse transcriptase expression is increased early in the barrett' s metaplasia, dysplasia, adenocarcinoma sequence [J]. J Gastrointest Surg,2000,4(2) :135 - 142.
  • 6Konagi Y, Kabayashi D, Yajima T, et al. Telomerase activity is down regulated via decreases in hTERT but not TEP1 mRNA or hTERC during the differentiation of leukemic cells [ J ]. Anticancer Res, 2000,20 ( 2 ) : 773 - 778.
  • 7Sui G, Soohoo C, Affar EIB, et al. A DNA vector based RNAitechnology to supress gene expression in mammalian cells [ J ]. ProcNatl Acad Sci, 2002,99 ( 8 ) : 5515 - 5520.
  • 8Zou L,Zhang P,Luo C,et al. shRNA -targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity [ J ]. Cancer Chemother Pharmacol, 2006,57 (3) :328 - 334.
  • 9Suzuki T,Suziki Y,Fujioka T. Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer [ J]. J Urol, 1999,162:2217 - 2220.
  • 10Glasgow JN, Everts M, Curiel DT. Transductional targeting of adenovirus vectors for gene therapy [ J ]. Cancer Gene Ther, 2006,13(9) :830 -844.

引证文献8

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部